Local estrogen replacement therapy in postmenopausal atrophic vaginitis: Efficacy and safety of low dose 17β-estradiol vaginal tablets

Clinical and Experimental Obstetrics and Gynecology

Volumn 32, Issue 2, 2005, Pages 111-113

  Mainini, G ^a   Scaffa, C ^a   Rotondi, M ^a,b   Messalli, E M ^a   Quirino, L ^a   Ragucci, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NONE   (Italy)

Author keywords

17 estradiol vaginal tablets; Atrophic vaginitis; Estrogen replacement therapy

Indexed keywords

ESTRADIOL;

ADULT; AGED; ARTICLE; DRUG EFFICACY; DRUG SAFETY; ENDOMETRIUM HYPERPLASIA; ERYTHEMA; ESTROGEN THERAPY; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; RASH; SIDE EFFECT; SPOTTING; TREATMENT OUTCOME; UTERUS BLEEDING; VAGINA BLEEDING; VAGINA SECRETION; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; AGED; ATROPHY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PATIENT SATISFACTION; POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VAGINITIS;

EID: 23044494048     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Greendale G.A., Judd H.L.: "The menopause: health implications and clinical management". J. Am. Geriatr. Soc., 1993, 41, 426.
2. Cardozo L., Bachmann G., McClish D., Fonda D., Birgerson L.: "Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee". Obstet. Gynecol., 1998, 92, 722.
3. Bachmann G.A., Nevadunsky N.S.: "Diagnosis and treatment of atrophic vaginitis". Am. Fam. Physician., 2000, 10, 3090.
4. Pandit L., Ouslander J.G.: "Postmenopausal vaginal atrophy and atrophic vaginitis". Am. J. Med. Sci., 1997, 314, 228.
5. Beard M.K.: "Atrophic vaginitis. Can it be prevented as well as treated?". Postgrad. Med., 1992, 91, 257.
6. Mettler L., Olsen P.G.: "Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets". Maturitas, 1991, 14, 23.
7. Beard M.K., Curtis L.R.: "Libido, menopause, and estrogen replacement therapy". Postgrad. Med., 1989, 86, 225.
8. Notelovitz M.: "Urogenital aging: solutions in clinical practice". Int. J. Gynaecol. Obstet., 1997, 59 (suppl. 1), S35.
9. Simunic V., Banovic I., Ciglar S., Jeren L., Pavicic Baldani D., Sprem M.: "Local estrogen treatment in patients with urogenital symptoms". Int. J. Gynecol. Obstet., 2003, 82, 187.
10. Pickar J.H., Thorneycroft I., Whitehead M.: "Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995". Am. J. Obstet. Gynecol., 1998, 178, 1087.
11. Suckling J., Lethaby A., Kennedy R.: "Local oestrogen for vaginal atrophy in postmenopausal women". Cochrane Database Syst. Rev., 2003, CD001500.
12. Eriksen P.S., Rasmussen H.: "Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study". Eur. J. Obstet. Gynecol. Reprod. Biol., 1992, 44, 137.
13. Dugal R., Hesla K., Sorom T., Aase K.M., Lillejoet O., Wickstrom E.: "Comparison of uselfulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy". Acta Obstet. Gynecol. Scand., 2000, 79, 293.
14. Rioux J.E., Devlin C., Gelfand M.M., Steinberg W.M., Hepburn D.S.: "17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis". Menopause, 2000, 7, 156.
15. Handa V.L., Bachus K.E., Johnston W.W., Robboy S.J., Hammond C.B.: "Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium". Obstet. Gynecol., 1994, 84, 215.
16. Botsis D., Kassanos D., Antoniou G., Vitoratos N., Zourlas P.A.: "Transvaginal sonography in postmenopausal women treated with low-dose estrogens locally administered". Maturitas, 1996, 23, 41.
17. Lupulescu A.: "Estrogen use and cancer incidence: a review". Cancer Invest., 1995, 13, 287.
18. Nilsson K., Heimer G.: "Low-dose oestradiol in the treatment of urogenital oestrogen deficiency-a pharmacokinetic and pharmacodynamic study". Maturitas, 1992, 15, 121.
19. Nygaard L., Drohse Kilde H., Andersen S.G., Henriksen L., Overby V: "Development and validation of a reversed-phase liquid Chromatographic method for analysis of degradation products of estradiol in Vagifem tablets". J. Pharm. Biomed. Anal., 2004, 34, 265.